Evidence map›Paper›PMID 27508415›Full record

ArticlePloS one2016

Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application.

Stefanie Reken, Sibylle Sturtz, Corinna Kiefer, Yvonne-Beatrice Böhler, Beate Wieseler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stefanie RekenDepartment of Drug Assessment, Institute for Quality and Efficiency in Health Care, Cologne, Germany.ORCID http://orcid.org/0000-0003-4239-504X
Sibylle SturtzDepartment of Medical Biometry, Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Corinna KieferDepartment of Medical Biometry, Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Yvonne-Beatrice BöhlerDepartment of Drug Assessment, Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Beate WieselerDepartment of Drug Assessment, Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Institute for Quality and Efficiency in Health Care · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The validity of mixed treatment comparisons (MTCs), also called network meta-analysis, relies on whether it is reasonable to accept the underlying assumptions on similarity, homogeneity, and consistency. The aim of this paper is to propose a practicable approach to addressing the underlying assumptions of MTCs. Using data from clinical studies of antidepressants included in a health technology assessment (HTA), we present a stepwise approach to dealing with challenges related to checking the above assumptions and to judging the robustness of the results of an MTC. At each step, studies that were dissimilar or contributed to substantial heterogeneity or inconsistency were excluded from the primary analysis. In a comparison of the MTC estimates from the consistent network with the MTC estimates from the homogeneous network including inconsistencies, few were affected by notable changes; that is, a change in effect size (factor 2), direction of effect or statistical significance. Considering the small proportion of studies excluded from the network due to inconsistency, as well as the number of notable changes, the MTC results were deemed sufficiently robust. In the absence of standard methods, our approach to checking assumptions in MTCs may inform other researchers in need of practical options, particularly in HTA.

Indexed as

Antidepressive AgentsHumansModels, StatisticalTechnology Assessment, BiomedicalTreatment OutcomeAntidepressive Agents

Identifiers

PMID27508415
PMCPMC4979893
OpenAlexW2492929796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.